Mumbai, Jan 20 UNI) Pharma major Cipla on Monday said the Company has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA)
The inspection was held at the Patalganga manufacturing facility of the Company
The inspcetion was carried from November 4, 2019 to November 13, 2019, the company said in a filing with the BSE.
UNI JS RJ 1500